Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
Negative Phase 3 Randomized Controlled Trials: Why Cancer Drugs Fail The Last Barrier?
HOME
/
Research Publications
/
Negative Phase 3 Randomized Controlled Trials: Why Cancer Drugs Fail The Last Barrier?